Evidence map›Paper›PMID 23806656›Full record

ArticleJournal of molecular biology2013

Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).

Abeer Rababa'h, John W Craft, Cori S Wijaya, Fatin Atrooz, Qiying Fan, Sonal Singh, Ashley N Guillory, Panagiotis Katsonis, Olivier Lichtarge, Bradley K McConnell

Abstract read
In one paragraph

Article in Journal of molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. mAKAP-a master scaffold for cardiac remodeling.Journal of cardiovascular pharmacology · 2015
    Review
  12. Review
  13. Single nucleotide variations: biological impact and theoretical interpretation.Protein science : a publication of the Protein Society · 2014
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Abeer Rababa'hDepartment of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas Medical Center, Houston, TX 77204, USA.
John W Craft
Cori S Wijaya
Fatin Atrooz
Qiying Fan
Sonal Singh
Ashley N Guillory
Panagiotis Katsonis
Olivier Lichtarge
Bradley K McConnell
University of Houston · USBaylor College of Medicine · US

Funding

Functional Determinnats in G Protein-coupled ReceptorsR01GM066099 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LICHTARGE, OLIVIER · 2003 to 2022
$7.5M
Comparative genomics of protein structure and functionR01GM079656 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LICHTARGE, OLIVIER · 2007 to 2019
$4.3M
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac ContractilitR01HL085487 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MCCONNELL, BRADLEY K · 2007 to 2011
$2.3M
Scaffolding Protein Interaction Network Regulates Cardiac Cell SignalingR15HL124458 · NHLBI · UNIVERSITY OF HOUSTON · PI MCCONNELL, BRADLEY K · 2015 to 2015
$452k
NHLBI NIH HHS HL085487NHLBI NIH HHS R01 HL085487NHLBI NIH HHS R15 HL124458NIGMS NIH HHS GM66099NIGMS NIH HHS GM79656NIGMS NIH HHS R01 GM066099NIGMS NIH HHS R01 GM079656
6 · The paper itself

Abstract

Protein kinase A (PKA) substrate phosphorylation is facilitated through its co-localization with its signaling partner by A-kinase anchoring proteins (AKAPs). mAKAP (muscle-selective AKAP) localizes PKA and its substrates such as phosphodiesterase-4D3 (PDE4D3), ryanodine receptor, and protein phosphatase 2A (PP2A) to the sarcoplasmic reticulum and perinuclear space. The genetic role of mAKAP, in modulating PKA/PDE4D3 molecular signaling during cardiac diseases, remains unclear. The purpose of this study was to examine the effects of naturally occurring mutations in human mAKAP on PKA and PDE4D3 signaling. We have recently identified potentially important human mAKAP coding non-synonymous polymorphisms located within or near key protein binding sites critical to β-adrenergic receptor signaling. Three mutations (P1400S, S2195F, and L717V) were cloned and transfected into a mammalian cell line for the purpose of comparing whether those substitutions disrupt mAKAP binding to PKA or PDE4D3. Immunoprecipitation study of mAKAP-P1400S, a mutation located in the mAKAP-PDE4D3 binding site, displayed a significant reduction in binding to PDE4D3, with no significant changes in PKA binding or PKA activity. Conversely, mAKAP-S2195F, a mutation located in mAKAP-PP2A binding site, showed significant increase in both binding propensity to PKA and PKA activity. Additionally, mAKAP-L717V, a mutation flanking the mAKAP-spectrin repeat domain, exhibited a significant increase in PKA binding compared to wild type, but there was no change in PKA activity. We also demonstrate specific binding of wild-type mAKAP to PDE4D3. Binding results were demonstrated using immunoprecipitation and confirmed with surface plasmon resonance (Biacore-2000); functional results were demonstrated using activity assays, Ca(2+) measurements, and Western blot. Comparative analysis of the binding responses of mutations to mAKAP could provide important information about how these mutations modulate signaling.

Indexed as

A Kinase Anchor ProteinsAmino Acid SubstitutionAnimalsBinding SitesCHO CellsCricetinaeCricetulusCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 4HEK293 CellsHumansMyocardiumPhosphorylationPolymorphism, Single NucleotideProtein BindingProtein Interaction Domains and MotifsAKAP6 protein, humanA Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesCyclic Nucleotide Phosphodiesterases, Type 43-isobutyl-1-methylxanthineAKAPA-kinase anchoring proteinbeta-adrenergic receptorcAMP-response element bindingChinese hamster ovaryCHOCREBETevolutionary traceG-protein coupled receptor kinase 2GRK2heart failureHEKHFhuman embryonic kidneyhypertrophyIBMXimmunoprecipitationmAKAPmuscle-selective A-kinase anchoring proteinNational Center for Biotechnology InformationNCBINFATcnuclear factor of activated T cellsPDEPDE4D3phosphodiesterasephosphodiesterase-4D3PKAPP2APP2Bprotein kinase Aprotein phosphatase 2Aprotein phosphatase 2B, calcineurinresponse unitRUryanodine receptorsRyR2SPRsurface plasmon resonanceUCSCUniversity of California Santa Cruzwild typeWTβ-adrenergic receptorβ-AR

Identifiers

PMID23806656
PMCPMC3808176
OpenAlexW2040411408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.